Clinical Trials Highlight Advances in Neuroendocrine Tumor Research Research into neuroendocrine tumors (NETs) continues to progress, with clinical trials exploring both new treatment approaches and improvements to existing therapies. Recent updates highlight progress in targeted radiopharmaceutical therapies, regulatory developments that could expand treatment access, and early-stage studies investigating innovative immune-based treatments. In this roundup, we … Continue reading NETRF Clinical Trial Roundup: March 2026